Status:
COMPLETED
Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
Lead Sponsor:
University of Palermo
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The study aims to evaluate arterial stiffness and endothelial function indexes and their relationship with clinic and laboratory varible in a group of diabetic patients in treatment with dulaglutide
Detailed Description
46 patients with type 2 diabetes mellitus were recruited at the Internal Medicine with Stroke care ward of the University hospital of Palermo "P. Giaccone" from April 2017 to April 2018. For all patie...
Eligibility Criteria
Inclusion
- diabetes mellitus
Exclusion
- cancer, severe ckd, end stage liver disease
Key Trial Info
Start Date :
April 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2018
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT03824002
Start Date
April 1 2017
End Date
April 20 2018
Last Update
January 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Internal Medicine Ward, University of Palermo
Palermo, Italy, 90127